Clin2
NCT07538674Possibly a fitNot yet recruiting

Traditional Chinese medicine ointment for age-related muscle loss

Sarcopenia in Elderly

Part of Bones, joints & muscles clinical trials.

This trial tests a traditional Chinese medicine ointment, applied externally, to help older adults with sarcopenia (muscle loss) improve muscle strength and physical function. Researchers want to see if it is safe and works as an add-on to usual care.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
60 years to 80 years
Study type
Interventional

Who can take part

  • You must be between 60 and 80 years old.
  • You must have a diagnosis of sarcopenia (age-related muscle loss) from a doctor.
  • You must be able to take oral (by mouth) medications and attend follow-up visits.
  • You must be generally able to move and care for yourself (not bedridden or paralyzed).
  • You must not have severe medical conditions like active cancer, major infections, or heart failure.
  • You must not have taken traditional Chinese medicine in the past month.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07072195Recruiting· Phase 2
A study of AMC6156 for people with muscle loss

This trial tests an investigational drug called AMC6156 to see if it can help improve muscle mass and strength in older adults with sarcopenia (age-related muscle loss). Participants will also follow exercise and nutrition guidance.

Seongnam-si, Gyeonggi-do
NCT07390552Recruiting· Phase 2
Study of PLH-2301 for muscle loss in older adults

This trial tests an experimental medicine called PLH-2301 to see if it can help improve muscle strength and function in people with age-related muscle loss (sarcopenia). It may be an option if you are 65 or older, have been diagnosed with sarcopenia, and can walk on your own.

Seongnam-si, Gyeonggi-do
NCT06643780Recruiting· Phase 4
Denosumab for muscle loss in older adults with osteoporosis

This study tests whether a drug called Denosumab, which is used to treat bone loss, can also help improve muscle strength and mass in older adults who have both osteoporosis and sarcopenia. If you qualify, you would receive the drug and be monitored over time to see if it helps your bones and muscles.

Hong Kong
NCT06991855Recruiting
Nutritional supplements for muscle health in older adults

This trial tests if taking leucine and omega-3 fatty acids can improve muscle mass and strength in older adults with low muscle health. It looks at people who have lost muscle and strength or walk slowly.

Linkou District
NCT07668180Not yet recruiting· Phase 2
Injection for muscle loss in older adults

This study tests an investigational injection (IN-207907) to see if it can improve muscle mass and strength in older adults with sarcopenia (age-related muscle loss). Participants will receive the injection and be monitored for safety and effectiveness.

NCT07620938Recruiting· Phase 2
TJ0113 capsule for treating muscle loss in older adults

This study tests a new capsule called TJ0113 to see if it can help older adults with sarcopenia (muscle loss) improve their muscle strength and physical function. It's a phase 2 study, meaning the drug is being tested for safety and effectiveness.

Hangzhou, Zhejiang

Hear when a new Sarcopenia in Elderly trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.